Cutaneous adverse reactions to fluoroquinolones. 2011

Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
Department of Dermatology, Faculty of Medicine, Adverse Drug Reaction Center, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

BACKGROUND To date, even though there are some large studies on adverse reactions related to fluoroquinolones, there is no comprehensive study focusing on cutaneous adverse drug reactions associated with their use. OBJECTIVE To demonstrate the pattern of cutaneous reaction related to the administration of each type of fluoroquinolone and to study the cross-sensitivity between various types of fluoroquinolones. METHODS Voluntary reports of any adverse events associated with fluoroquinolone use as reported from January 2004 to December 2008 and obtained from the Adverse Drug Reaction Center, Siriraj Hospital, Thailand, were reviewed. RESULTS Among 166,736 patients who had been treated with fluoroquinolones, the prevalences of adverse reaction and cutaneous adverse reaction were 0.13% and 0.09%, respectively. The prevalence of cutaneous reaction to individual fluoroquinolones varies between 0.04% and 0.37%. One hundred fifty-one subjects were enrolled. Most cutaneous reactions were attributed to ciprofloxacin (n = 93), and the most frequent adverse cutaneous reaction seen was maculopapular rash (39.7%). Thirteen cases (8.6%) involved a previous history of fluoroquinolone hypersensitivity; among these, 15.4% had cross-reactivity potential. CONCLUSIONS These data suggest that individual fluoroquinolones are responsible for different types and frequencies of cutaneous reactions, with some potentiality of cross-reactivity between different generations.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013785 Thailand Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city. Kingdom of Thailand,Siam

Related Publications

Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 1996, Therapie,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
February 1989, Clinical and investigative medicine. Medecine clinique et experimentale,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2020, Clinics in dermatology,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2002, American journal of clinical dermatology,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2018, Revista medica del Instituto Mexicano del Seguro Social,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2015, Allergologia et immunopathologia,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2008, Actas dermo-sifiliograficas,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2002, American journal of clinical dermatology,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2003, Revue medicale de Liege,
Kanokvalai Kulthanan, and Leena Chularojanamontri, and Araya Manapajon, and Naruemon Dhana, and Kowit Jongjarearnprasert
January 2010, Acta dermatovenerologica Croatica : ADC,
Copied contents to your clipboard!